Acetazolamide improves vision in patients with idiopathic intracranial hypertension

  • April 23, 2014

Acetazolamide in combination with a weight-reduction diet slightly improved vision in patients with idiopathic intracranial hypertension, according to a study.

The Idiopathic Intracranial Hypertension Treatment Trial, a multicenter, randomized, double-masked study, included 161 women and four men with idiopathic intracranial hypertension and mild vision loss.

Eighty-six patients received acetazolamide, and 79 patients received a placebo. Dosage was up to 4 g daily. All patients were on a low-sodium weight-reduction diet.
Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More »
More »
More »
  • Meeting News Coverage
  • OSN meeting
  • ASCRS 2014
  • Live onsite coverage from the Ophthalmology Innovation Summit and the American Society of Cataract and Refractive Surgeons annual meeting in Boston will begin on Thursday, April 24.
More »
  • Health Care Update
  • Medicare lab payments
  • New law will modernize Medicare lab payments: What physicians need to know. Analysis from Arnold & Porter LLP.
More »